A research paper titled “Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections” has been published in the peer-reviewed Proceedings of the National Academy ...

influenza and other infections, sidestepping the virus itself to target the host cell instead. Ansun’s lead drug candidate, Fludase (DAS181), removes a host cell-surface component used by ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Discover the latest drugs and treatment options in the Influenza Pipeline. Dive into DelveInsight's comprehensive report ...

With the exception of Novartis's Madin–Darby canine kidney (MDCK) cell-based vaccine Optaflu ... Control and Prevention. Projected influenza vaccination target population sizes, vaccination ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, and serological analyses. On February 28, 2025, WHO announced the ...

The potential target, the FLT1 gene, contributes to the production of a protein, fetal hemoglobin, whose presence is already known to improve the lifespan of people with sickle cell disease.